Rational considerations about development of live attenuated Yersinia pestis vaccines
about
Surface display on lactic acid bacteria without genetic modification: strategies and applications.A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis.Assessment of Live Plague Vaccine Candidates.Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine.
P2860
Rational considerations about development of live attenuated Yersinia pestis vaccines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rational considerations about development of live attenuated Yersinia pestis vaccines
@en
Rational considerations about development of live attenuated Yersinia pestis vaccines.
@nl
type
label
Rational considerations about development of live attenuated Yersinia pestis vaccines
@en
Rational considerations about development of live attenuated Yersinia pestis vaccines.
@nl
prefLabel
Rational considerations about development of live attenuated Yersinia pestis vaccines
@en
Rational considerations about development of live attenuated Yersinia pestis vaccines.
@nl
P2860
P1476
Rational considerations about development of live attenuated Yersinia pestis vaccines
@en
P2093
P2860
P304
P356
10.2174/1389201014666131226122243
P577
2013-01-01T00:00:00Z